We've seen connected scales that provide oxygen levels and heart rates, but they have nothing on the sheer range of data coming from Runtastic's imminent Libra scale. In addition to basic weight and body fat measurements, the Bluetooth-based sensor can also calculate body mass index, bone mass, ...
Source: http://feeds.engadget.com/~r/weblogsinc/engadget/~3/B2C4oOar47o/FILE - This Feb. 18, 2013 file photo shows actress Ellie Kemper at the Vanity Fair and Juicy Couture Celebration for the 2013 Vanities Calendar at the Chateau Marmont in Los Angeles. NBC has ordered 13 episodes of a new singlecam comedy from multiple Emmy Award winners Tina Fey and Robert Carlock. Ellie Kemper is set to star. (Photo by Jordan Strauss/Invision/AP, File)
LOS ANGELES (AP) — NBC says it's ordering 13 episodes of a new comedy created by Tina Fey and starring Ellie Kemper of "The Office."
The network says Kemper will play a woman who flees a doomsday cult and begins a new life in New York city. The actress had joined "The Office" as Erin the receptionist in the show's 2009 season.
NBC says Fey created the new series with Robert Carlock, who was an executive producer on her Emmy-winning series "30 Rock." The pair will join in writing the new comedy and serve as executive producers along with David Miner.
NBC says the new show, as yet untitled, is scheduled to debut in fall 2014.
Spending time with mommy at work before the Halloween festivities later, Honor joined Jessica Alba on the set of "How to Make Love Like an Englishman" on Thursday (October 31).
The "Sin City" star looked cute in a purple striped sweater, blue jeans, and black boots while her adorable little girl skipped around in a pink tutu.
In the upcoming rom-com directed by Tom Vaughan, a Cambridge poetry professor begins to re-evaluate his life of Byronic excess.
Co-starring with Jessica in the movie are Salma Hayek, Pierce Brosnan, Malcolm McDowell, and Marlee Matlin.
A night out with training partners from Reign MMA quickly turned into chaos for Uriah Hall, thanks to Jason Miller. Hall and 'Mayhem' were involved in a nasty incident Oct. 25 while attending BAMMA USA's Badbeat 11 event in Commerce, Calif. After being taunted with racial slurs by Miller, Hall threw a punch.
Now a week removed, Hall says he was merely an onlooker looking to settle tensions before being singled out by Miller.
"Initially, I saw a big bald-headed dude," Hall tells MMA Weekly. "Then it hit me that it was Mayhem Miller. I was a little star struck, at first. He was yelling at me though, and wanted to talk to the girl. I guess it was his ex. I tried to stay calm and just diffuse things. I was still kind of shocked that it was all happening."
After his punch 'just barely clipped' Miller, the pair were separated by security. It didn't stop there. Hall says following the confrontation with Miller, 'Mayhem' continued the onslaught via Twitter and text messages.
"I don't know how he got my number," Hall says. "I asked and his response was, ‘I am Mayhem Miller, I know everything.'"
Miller, seemingly unrepentant, only looks more bizarre after comments made by former acquaintances revealing personal anecdotes. Hall, who faces Chris Leben at UFC 168 on Dec. 28, says he's past being angry and simply hopes Miller takes the steps to get help.
5 MUST-READ STORIES
Lil Nog out. Just days after being set to face Alexander Gustafsson next year in London, Antonio Rogerio Nogueira has withdrawn with an injury.
WADA on the house. Josh Barnett will have random, extensive pre-fight drug screenings paid for by the UFC.
TRT for a title shot. Vitor Belfort says he'd stop testosterone replacement therapy if he were granted a UFC middleweight title shot. "I've already said that, if they agree with it, I would (stop doing TRT)," he said. "No problem at all. If they want me to get there in a disadvantage, that's ok."
20 in 20. Chuck Mindenhall's series hits 2010, the year we said hello (goodbye?) to the WEC and Ferrari World.
JDS not impressed. Junior dos Santos says Cain Velasquez' performance at UFC 166 didn't necessarily prove he was better. "He applied pressure, grabbing hold of me and avoiding the fight, making the fight boring, making the audience boo a lot. An effective strategy to win, but he didn't prove he was the better fighter."
MEDIA STEW
Michael Bisping walks around Manchester with James Haskell.
Chael Sonnen and Rashad Evans put friendship aside.
King Mo talks Emanuel Newton.
And a pre-fight interview.
Friend of the MR Ottavia Bourdain teaches some BJJ.
Halloween special from Tommy Toe Hold.
Jordan Mein's dad gets a quick KO from last weekend.
Super Fight League 31.
TWEETS
Chael had some thoughts on Lil Nog pulling out.
New standard?
Kinda came out of nowhere.
Diego poetry will always have a home here.
What is?
Calling out Demian Maia?
Halloween.
FIGHT ANNOUNCEMENTS
Announced yesterday (Oct. 31 2013)
cancelled Antonio Rogerio Nogueira vs. Alexander Gustafsson at UFC Fight Night in London.
FANPOST OF THE DAY
Today's Fanpost of the Day comes via Bradley Bates.
Rampage vs. Beltran? Wake me up when it's done
You've probably heard the news today that former UFC light-heavyweight Joey Beltran has stepped in to replace the injured Tito Ortiz and face Quinton 'Rampage' Jackson at Bellator 108.
Whilst this is good news for Bellator as they get to put on a fight with what is probably their biggest draw, it's bad news for us fight fans. With a combined four wins in their last 11 fights, neither guy is exactly riding high at the moment. Nor did either guy light up the UFC, at least not in the past four and a half years since 'Rampage' knocked out Wanderlei Silva at UFC 92.
Beltran (14-9-0(1) MMA, 0-0 BMMA) is a known brawler, but isn't exactly a finisher, having not finished a fight since his UFC debut in 2010. Rampage (32-11 MMA, 0-0 BMMA) on the other hand is known for his vicious knockout power, but again it's something we haven't seen as of late. You would have to go back to the above mentioned, albeit spectacular, knockout of Wanderlei Silva in 2008 for Rampage's last finish.
With both fighters last three wins coming by decision, it doesn't look as though it will be a 'balls to the wall' fight. Then there's the question of what happens to the winner? If Rampage wins do Bellator still do the Tito fight? And if Beltran wins, the Tito fight, for Rampage at least, wouldn't be easy to sell.
...
Check out the rest of the post here.
Found something you'd like to see in the Morning Report? Just hit me up on Twitter @SaintMMA and we'll include it in tomorrow's column.
Guilherme Cruz, MMA Fighting
Hernani Perpetuo is the latest addition to the UFC’s welterweight division.
Two months after winning the Shooto world title with a unanimous decision victory over MMA veteran Tommy Depret at Shooto Brazil 42, Perpetuo (17-3, 1 no-contest), a Nova Uniao product, signed a deal with the UFC and is expected to make his Octagon debut early 2014.
"I’ve signed a contract with the UFC today," Perpetuo told MMAFighting.com on Thursday, confirming an initial report by Combate.
"I already expected to sign with a major promotion after I won the Shooto title, and I’m looking forward my first fight."
Perpetuo’s five-round war with Depret was the ninth bout of his undefeated streak, which includes two knockouts and one submission.
"I have to win my first fight and then climb the rankings step by step," he said. "The Shooto title was very important to open doors and get me in the UFC."
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tUd45S_aDbDwz7V3rwOq1btf9LJf1lbiLtIg54Ne6iU9dZhwVMHRQWBQbDLjM4MV6JpD9IFyVc4i3qig6FosJMWuKJO9F0o9tg9yxBJ-4=s0-d){kind=small}
PUBLIC RELEASE DATE: 31-Oct-2013
ShareContact: Patrick Smith
psmith88@jhmi.edu
410-955-8242
Johns Hopkins Medicine
Results of a Johns Hopkins study published today in the journal Diabetes Care found that young and middle-aged women with type 2 diabetes are at much greater risk of coronary artery disease than previously believed.
Generally, women under 60 are at far less risk for coronary artery disease than men of the same age. But among women of that age who have diabetes, their risk of heart disease increases by up to four times, making it roughly equal to men's risk of this same form of heart disease.
"Our findings suggest that we need to work harder to prevent heart disease in women under 60 who have diabetes," says Rita Rastogi Kalyani, M.D., M.H.S., endocrinologist at the Johns Hopkins University School of Medicine and lead study author. "This study tells us that women of any age who have diabetes are at a high risk for coronary artery disease."
While men generally have a higher incidence of heart disease than women, the study found that diabetes had little or no effect on men's heart disease risk.
Kalyani said the new study is believed to be the first to focus specifically on gender differences in coronary artery disease among younger and middle-aged people with diabetes.
For the research, she and her colleagues analyzed data from more than 10,000 participants in three widely regarded studies: the GeneSTAR Research Program, the Multi-Ethnic Study of Atherosclerosis and the National Health and Nutrition Examination Survey (NHANES) III. None of the participants had a history of heart disease. All three studies yielded similar gender differences in rates of diabetes and the risk of developing heart disease.
"Our study adds to growing evidence that gender differences exist in the risk of coronary artery disease brought on by diabetes," Kalyani says.
Interestingly, in both women and men, these findings were unrelated to differences in obesity and other traditional cardiovascular risk factors such as high blood pressure, cholesterol and smoking.
Kalyani and her colleagues offer several possible explanations for the increased risk. There may be distinct genetic and hormonal factors related to the development of heart disease by gender. Differences in adherence to heart-healthy lifestyle behaviors, compliance and treatment of cardiovascular treatments between genders are also possible but need to be further investigated, Kalyani says. Also, the relationship of diabetes duration and glucose control to risk of heart disease remains unclear.
###
In addition to Kalyani, the study's authors are Mario Lazo, M.D.; Pamelo Ouyang, M.B.B.S.; Karinne Chevalier, M.S.; Frederick Brancati, M.D., M.H.S.; Diane Becker, Sc.D., M.P.H.; and Dhananjay Vaidya, Ph.D., M.P.H., of the Johns Hopkins University School of Medicine, as well as Evrim Turkbey, M.D., of Radiology and Imaging Sciences at the National Institutes of Health Clinical Center.
About Johns Hopkins Medicine
Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.
Media Contacts: Patrick Smith
410-955-8242; psmith88@jhmi.edu or
Helen Jones
410-502-9422; hjones49@jhmi.edu
Share
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
PUBLIC RELEASE DATE: 31-Oct-2013
ShareContact: Patrick Smith
psmith88@jhmi.edu
410-955-8242
Johns Hopkins Medicine
Results of a Johns Hopkins study published today in the journal Diabetes Care found that young and middle-aged women with type 2 diabetes are at much greater risk of coronary artery disease than previously believed.
Generally, women under 60 are at far less risk for coronary artery disease than men of the same age. But among women of that age who have diabetes, their risk of heart disease increases by up to four times, making it roughly equal to men's risk of this same form of heart disease.
"Our findings suggest that we need to work harder to prevent heart disease in women under 60 who have diabetes," says Rita Rastogi Kalyani, M.D., M.H.S., endocrinologist at the Johns Hopkins University School of Medicine and lead study author. "This study tells us that women of any age who have diabetes are at a high risk for coronary artery disease."
While men generally have a higher incidence of heart disease than women, the study found that diabetes had little or no effect on men's heart disease risk.
Kalyani said the new study is believed to be the first to focus specifically on gender differences in coronary artery disease among younger and middle-aged people with diabetes.
For the research, she and her colleagues analyzed data from more than 10,000 participants in three widely regarded studies: the GeneSTAR Research Program, the Multi-Ethnic Study of Atherosclerosis and the National Health and Nutrition Examination Survey (NHANES) III. None of the participants had a history of heart disease. All three studies yielded similar gender differences in rates of diabetes and the risk of developing heart disease.
"Our study adds to growing evidence that gender differences exist in the risk of coronary artery disease brought on by diabetes," Kalyani says.
Interestingly, in both women and men, these findings were unrelated to differences in obesity and other traditional cardiovascular risk factors such as high blood pressure, cholesterol and smoking.
Kalyani and her colleagues offer several possible explanations for the increased risk. There may be distinct genetic and hormonal factors related to the development of heart disease by gender. Differences in adherence to heart-healthy lifestyle behaviors, compliance and treatment of cardiovascular treatments between genders are also possible but need to be further investigated, Kalyani says. Also, the relationship of diabetes duration and glucose control to risk of heart disease remains unclear.
###
In addition to Kalyani, the study's authors are Mario Lazo, M.D.; Pamelo Ouyang, M.B.B.S.; Karinne Chevalier, M.S.; Frederick Brancati, M.D., M.H.S.; Diane Becker, Sc.D., M.P.H.; and Dhananjay Vaidya, Ph.D., M.P.H., of the Johns Hopkins University School of Medicine, as well as Evrim Turkbey, M.D., of Radiology and Imaging Sciences at the National Institutes of Health Clinical Center.
About Johns Hopkins Medicine
Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.
Media Contacts: Patrick Smith
410-955-8242; psmith88@jhmi.edu or
Helen Jones
410-502-9422; hjones49@jhmi.edu
Share
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
FILE - In this July 15, 2013 file photo, two signs that read "Who Lobbied For This?" and "We Need Healthcare Options, Not Obstacles" are held by attendees of a rally in front of Dallas city hall where a group of nearly 200 gathered to protest the approval of sweeping new restrictions on abortion in Texas. A U.S. appeals court on Thursday, Oct. 31, 2013, issued a ruling reinstating most of Texas' tough new abortion restrictions, which means as many as 12 clinics will not be able to perform the procedure starting as soon as Friday. (AP Photo/Tony Gutierrez, File)
FILE - In this July 15, 2013 file photo, two signs that read "Who Lobbied For This?" and "We Need Healthcare Options, Not Obstacles" are held by attendees of a rally in front of Dallas city hall where a group of nearly 200 gathered to protest the approval of sweeping new restrictions on abortion in Texas. A U.S. appeals court on Thursday, Oct. 31, 2013, issued a ruling reinstating most of Texas' tough new abortion restrictions, which means as many as 12 clinics will not be able to perform the procedure starting as soon as Friday. (AP Photo/Tony Gutierrez, File)
File - In this Oct. 29, 2013 file photo, Dottie and Tom Knodell, opponents of abortion, hold signs outside a Planned Parenthood Clinic, in San Antonio. A U.S. appeals court on Thursday, Oct. 31, 2013, issued a ruling reinstating most of Texas' tough new abortion restrictions, which means as many as 12 clinics will not be able to perform the procedure starting as soon as Friday. (AP Photo/Eric Gay, File)
AUSTIN, Texas (AP) — A federal appeals court on Thursday ruled that most of Texas' tough new abortion restrictions can take effect immediately — a decision that means a third of the state's clinics that perform the procedure won't be able to do so starting as soon as Friday.
A panel of judges at the 5th Circuit Court of Appeals in New Orleans said the law requiring doctors to have admitting privileges at a nearby hospital can take effect while a lawsuit challenging the restrictions moves forward. The panel issued the ruling three days after District Judge Lee Yeakel said the provision serves no medical purpose.
In its 20-page ruling, the appeals court panel acknowledged that the provision "may increase the cost of accessing an abortion provider and decrease the number of physicians available to perform abortions." However, the panel said that the U.S. Supreme Court has held that having "the incidental effect of making it more difficult or more expensive to procure an abortion cannot be enough to invalidate" a law that serves a valid purpose, "one not designed to strike at the right itself."
The panel left in place a portion of Yeakel's order that prevents the state from enforcing the U.S. Food and Drug Administration protocol for abortion-inducing drugs in cases where the woman is between 50 and 63 days into her pregnancy. Doctors testifying before the court had said such women would be harmed if the protocol were enforced.
After Yeakel halted the restrictions, Texas Attorney General Greg Abbott had made an emergency appeal to the conservative 5th Circuit, arguing that the law requiring doctors to have admitting privileges is a constitutional use of the Legislature's authority.
"This unanimous decision is a vindication of the careful deliberation by the Texas Legislature to craft a law to protect the health and safety of Texas women," Abbott, a Republican who is running for governor, said in a written statement.
Lawyers for Planned Parenthood and other abortion providers had argued that the regulations do not protect women and would shut down a third of the 32 abortion clinics in Texas.
Twelve of Texas' abortion clinics won't be able to perform the procedure starting as soon as Friday.
In a statement Thursday, Planned Parenthood said the appeals court decision means "abortion will no longer be available in vast stretches of Texas."
"This fight is far from over," Planned Parenthood President Cecile Richards said in the statement. "This restriction clearly violates Texas women's constitutional rights by drastically reducing access to safe and legal abortion statewide."
The court's order is temporary until it can hold a complete hearing, likely in January.
The restrictions are among the toughest in the nation and gained notoriety when Democratic state Sen. Wendy Davis launched a nearly 13-hour filibuster against them in June. Davis has since launched her own gubernatorial campaign and could face Abbott in the November 2014 election. Republican Gov. Rick Perry has said he will not seek another term.
The law that the Legislature passed this summer also bans abortions at 20 weeks of pregnancy and beginning in October 2014 requires doctors to perform all abortions in surgical facilities.
Officials for one chain of abortion clinics testified in the trial that Yeakel oversaw that they've tried to obtain admitting privileges for their doctors at 32 hospitals, but so far only 15 accepted applications and none have announced a decision. Many hospitals with religious affiliations will not allow abortion doctors to work there, while others fear protests if they provide privileges. Many have requirements that doctors live within a certain radius of the facility, or perform a minimum number of surgeries a year that must be performed in a hospital.
Associated PressSource: http://hosted2.ap.org/APDEFAULT/386c25518f464186bf7a2ac026580ce7/Article_2013-10-31-Texas%20Abortion%20Restrictions-Lawsuit/id-42429cd6e70b44118d149c43825ee240
